NovoCure (NVCR) Enterprise Value (2014 - 2026)
NovoCure recorded quarterly Enterprise Value of -$432.0 million in Q1 2026, down 317.84% quarter-over-quarter from -$103.4 million in Q4 2025, and up 53.5% year-over-year from -$281.4 million in Q1 2025.
NovoCure's Enterprise Value history runs 13 years deep, the most recent figure standing at -$432.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 53.5% year-over-year to -$432.0 million; the TTM figure through Mar 2026 stood at -$432.0 million (up 53.5% YoY), while the FY2025 annual figure was -$103.4 million, up 89.23% from the prior year.
- Enterprise Value came in at -$432.0 million for Q1 2026 at NovoCure, down from -$103.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$103.4 million in Q4 2025 to a low of -$969.4 million in Q4 2022.
- A 5-year average of -$555.8 million and a median of -$432.0 million in 2026 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 366.22% in 2024 and jumped 89.23% in 2025, its largest moves.
- NovoCure's Enterprise Value stood at -$969.4 million in 2022, then advanced by 6.07% to -$910.6 million in 2023, then slipped by 5.41% to -$959.9 million in 2024, then surged by 89.23% to -$103.4 million in 2025, then plunged by 317.84% to -$432.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$432.0 million, -$103.4 million, and -$344.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.17 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -3.09 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -426.00 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | -432.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -432.00 Mn |
| Dec 31, 2025 | -103.39 Mn |
| Sep 30, 2025 | -344.64 Mn |
| Jun 30, 2025 | -152.13 Mn |
| Mar 31, 2025 | -929.13 Mn |
| Dec 31, 2024 | -959.87 Mn |
| Sep 30, 2024 | -959.90 Mn |
| Jun 30, 2024 | -168.44 Mn |
| Mar 31, 2024 | -870.15 Mn |
| Dec 31, 2023 | -910.62 Mn |
| Sep 30, 2023 | -921.25 Mn |
| Jun 30, 2023 | -157.49 Mn |
| Mar 31, 2023 | -186.64 Mn |
| Dec 31, 2022 | -969.43 Mn |
| Sep 30, 2022 | -244.04 Mn |
| Jun 30, 2022 | -948.52 Mn |
| Mar 31, 2022 | -191.63 Mn |
| Dec 31, 2021 | -937.70 Mn |
| Sep 30, 2021 | -933.79 Mn |
| Jun 30, 2021 | -360.59 Mn |
| Mar 31, 2021 | -864.40 Mn |
| Dec 31, 2020 | -842.58 Mn |
| Sep 30, 2020 | -235.38 Mn |
| Jun 30, 2020 | -346.71 Mn |
| Mar 31, 2020 | -182.71 Mn |
| Dec 31, 2019 | -179.42 Mn |
| Sep 30, 2019 | -210.17 Mn |
| Jun 30, 2019 | -284.58 Mn |
| Mar 31, 2019 | -256.60 Mn |
| Dec 31, 2018 | -142.76 Mn |
| Sep 30, 2018 | -227.70 Mn |
| Jun 30, 2018 | -218.96 Mn |
| Mar 31, 2018 | -113.76 Mn |
| Dec 31, 2017 | -80.72 Mn |
| Sep 30, 2017 | -186.56 Mn |
| Jun 30, 2017 | -184.38 Mn |
| Mar 31, 2017 | -189.25 Mn |
| Dec 31, 2016 | -219.63 Mn |
| Sep 30, 2016 | -235.55 Mn |
| Jun 30, 2016 | -200.85 Mn |
| Mar 31, 2016 | -235.77 Mn |
| Dec 31, 2015 | -269.42 Mn |
| Sep 30, 2015 | -137.32 Mn |
| Jun 30, 2015 | -106.51 Mn |
| Mar 31, 2015 | -74.22 Mn |
| Dec 31, 2014 | -102.61 Mn |
| Sep 30, 2014 | -79.98 Mn |